Management of hyperglycemia and diabetes in an outpatient cardiology practice

Samer Jabbour1, Susanna E Bedell, Rami Alharethi

  • 1Lown Cardiovascular Center, Harvard Medical School, 21 Longwood Avenue, Brookline, MA 02446, USA.

Cardiology
|July 30, 2002
PubMed

Insights

Cardiologists inadequately manage diabetes and hyperglycemia in patients with cardiovascular disease. Guideline adherence for glycemic control, diet, and complications was poor, indicating a need for greater cardiologist involvement.

Area of Science:

  • Cardiology
  • Endocrinology
  • Public Health

Background:

  • Diabetes mellitus and hyperglycemia are prevalent conditions often co-occurring with cardiovascular disease.
  • Limited data exists on the management of diabetes and hyperglycemia by cardiologists in outpatient settings.
  • Cardiovascular disease management guidelines often do not fully integrate glycemic control strategies.

Purpose of the Study:

  • To determine the prevalence of overt and latent diabetes and hyperglycemia in deceased patients from an academic cardiology practice.
  • To assess the adherence of diabetes and hyperglycemia management to established clinical guidelines.
  • To identify gaps in care regarding glycemic control and cardiovascular complications in this patient population.

Main Methods:

  • Retrospective chart review of 128 deceased patients (mean age 78 years) from January 1995 to December 1997.
  • Identification of patients with recognized diabetes and undiagnosed hyperglycemia.
  • Evaluation of management practices against established guidelines for glycemic control, diet, and cardiovascular complications.

Main Results:

  • 22 patients had recognized diabetes, and 27 had undiagnosed hyperglycemia.
  • Management in both groups frequently deviated from established guidelines.
  • Deficiencies were noted in assessing long-term glycemic control, end-organ damage, dietary management, and cardiovascular complications.

Conclusions:

  • Cardiologists' management of diabetes and hyperglycemia in patients with cardiovascular disease often falls short of guideline recommendations.
  • There is a significant need for enhanced cardiologist involvement in the comprehensive care of diabetic and hyperglycemic patients.
  • Improved integration of diabetes management into cardiology practice is crucial for better patient outcomes.

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...